EndoGastric Solutions, Inc.: Series F $30M

Posted in I - Series F, Q - 3Q10, R - NORTH WEST, X - Device (GI), XX - WA

EndoGastric Solutions (Redmond, WA) a commercial-stage medical device company focused on endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI disorders, closed a $30M Series F financing. Participants have included Canaan Partners, Radius Ventures, Advanced Technology Ventures, Chicago Growth Partners, DeNovo Ventures, Foundation Medical Partners, MPM Capitaland [...]

Aug

2010

Calithera Biosciences, Inc.: Series A $40M

Posted in I - Series A, Q - 3Q10, R - WEST, X - Caspase, X - Oncology

Calithera Biosciences (San Francisco, CA) a preclinical-stage small molecule company focused on caspase activators for oncologic applications, closed a $40M Series A financing. Participants include Morgenthaler Ventures, U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital.

Jul

2010

Zeltiq, Inc.: Series D $25M

Posted in I - Series D, Q - 2Q10, R - WEST, X - Device (Lypolysis)

Zeltiq (Pleasanton, CA) a commercial-stage medical device company focused on lipolysis for fat reduction and other dermatological applications, closed a $25M Series D financing. Participants include Aisling Capital, Venrock, Frazier Healthcare Ventures and Advanced Technology Ventures.

Jul

2010

Coskata, Inc.: Series D $23.7M

Posted in I - Series D, Q - 2Q10, R - MID WEST, X - Biofuel, XX - IL

Coskata (Warrenville, IL) a development-stage bacterial fermentation biofuels company closed a $23.7M Series D financing. Participants include Total, Blackstone Group, Advanced Technology Ventures, Globespan Capital Partners, General Motors, GreatPoint Ventures and Khosla Ventures.

Jun

2010

Altura Medical, Inc.: Series A $20M

Posted in I - Series A, Q - 2Q10, R - WEST, X - Device (Aneurysm), XX - CA

Altura Medical (San Clemente, CA) a development-stage medical device company focused on the treatment of abdominal aortic aneurysms, closed a $20M Series A financing. Participants include New Leaf Venture Partners, Advanced Technology Ventures and SV Life Sciences.

Apr

2010

Catabasis Pharmaceuticals, Inc.: Series A $39.6M

Posted in I - Series A, Q - 2Q10, R - NORTH EAST, X - Inflammation, X - Metabolism, XX - MA

Catabasis Pharmaceuticals (Cambridge, MA) a preclinical-stage company focused on lipid mediators for the treatment of inflammatory and metabolic diseases, closed a $39.6M Series A financing. Participants include SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures.

Jan

2010

EndoGastric Solutions, Inc.: Series E $21.5M

Posted in I - Series E, Q - 4Q09, R - NORTH WEST, X - Device (GI), XX - WA

EndoGastric Solutions (Redmond, WA) a commercial-stage medical device company focused on endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI disorders, closed a $21.5M Series E financing. Participants have included Advanced Technology Ventures, Chicago Growth Partners, DeNovo Ventures, Foundation Medical Partners, MPM Capitaland Oakwood Medical Investors.

Note: 2009 [...]

Jan

2010

EndoGastric Solutions, Inc.: Series E $21.5M

Posted in I - Series E, Q - 4Q09, R - NORTH WEST, X - Device (GI), XX - WA

EndoGastric Solutions (Redmond, WA) a commercial-stage medical device company focused on endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI disorders, closed a $21.5 Series E financing. Participants have included Advanced Technology Ventures, Chicago Growth Partners, DeNovo Ventures, Foundation Medical Partners, MPM Capital and Oakwood Medical Investors.
Note: [...]

to top of page...